SEARCH

SEARCH BY CITATION

References

  • Adams D. H., Hanson G. R. and Keefe K. A. (2000) Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum. J. Neurochem. 75, 20612070.
  • Bittner S. E., Wagner G. C., Aigner T. G. and Seiden L. S. (1981) Effects of high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacol. Biochem. Behav. 14, 481486.
  • Bradberry C. W. and Roth R. H. (1989) Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett. 103, 97102.
  • Chapman D. E., Hanson G. R., Kesner R. P. and Keefe K. A. (2001) Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J. Pharmacol. Exp. Ther. 296, 520527.
  • Friedman S. D., Castaneda E. and Hodge G. K. (1998) Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav. 61, 3544.
  • Galloway M. P. (1990) Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse 6, 6372.
  • Gresch P. J. and Walker P. D. (1999) Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease. Neuroscience 93, 831841.
  • Grima B., Lamouroux A., Blanot F., Biguet N. F. and Mallet J. (1985) Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl Acad. Sci. USA 82, 617621.
  • Hotchkiss A. J. and Gibb J. W. (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257262.
  • Hotchkiss A. J., Morgan M. E. and Gibb J. W. (1979) The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase, and glutamate decarboxylase activities. Life Sci. 25, 13731378.
  • Johanson C. E., Balster R. L. and Bonese K. (1976) Self-administration of psychomotor stimulant drugs: the effects of unlimited access. Pharmacol. Biochem. Behav. 4, 4551.
  • Johnston L. D., O'Malley P. M. and Bachman J. G. (2001) Monitoring the Future National Survey Results on Drug Use, 1975–2000, Vol. I: Secondary School Students (NIH publication no. 01–4924). National Institute on Drug Abuse, Bethesda, MD.
  • Kogan F. J., Nichols W. K. and Gibb J. W. (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36, 363371.
  • Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S. and Hershey A. D. (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl Acad. Sci. USA 84,881885.
  • Lowry O. H., Rosebrough N., Farr A. and Randall R. (1951) Protein measurements with folin phenol reagent. J. Biol. Chem. 193, 265275.
  • Marshall J. F. (1979) Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control. Brain Res. 177, 311324.
  • Marshall J. F., Berrios N. and Sawyer S. (1980) Neostriatal dopamine and sensory inattention. J. Comp. Physiol. Psychol. 94, 833846.
  • Mattioli R., Schwarting R. K. and Huston J. P. (1992) Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1–11. Neuroscience 48, 595605.
  • Nikolaus S., Huston J. P., Korber B., Thiel C. and Schwarting R. K. (1997) Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion. Peptides 18, 11611168.
  • Nisenbaum L. K., Crowley W. R. and Kitai S. T. (1996) Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin mRNA expression. Brain Res. Mol. Brain Res. 37, 209216.
  • Pelleymounter M. A., Schlesinger K., Wehner J., Hall M. E. and Stewart J. M. (1988) Nigral 5-HT and substance P-induced enhancement of passive avoidance retention. Behav. Brain Res. 29, 159172.
  • Ricaurte G. A., Schuster C. R. and Seiden L. S. (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193, 153163.
  • Rogers R. D., Everitt B. J., Baldacchino A., Blackshaw A. J., Swainson R., Wynne K., Baker N. B., Hunter J., Carthy T., Booker E., London M., Deakin J. F., Sahakian B. J. and Robbins T. W. (1999) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20, 322339.
  • Sternberger L. (1979) The unlabeled antibody (PAP) method, introduction. J. Histochem. Cytochem. 27, 1657.
  • Volkow N. D., Chang L., Wang G.-J., Fowler J. S., Franceschi D., Sedler M., Gatley S. J., Miller E., Hitzermann R., Ding Y.-S. and Logan J. (2001a) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21, 94149418.
  • Volkow N. D., Chang L., Wang G.-J., Fowler J. S., Leonido-Yee M., Franceschi D., Sedler M. J., Gatley S. J., Hitzermann R., Ding Y.-S., Logan J., Wong C. and Miller E. N. (2001b) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158, 377382.
  • Walker P. D., Riley L. A., Hart R. P. and Jonakait G. M. (1991) Serotonin regulation of tachykinin biosynthesis in the rat neostriatum. Brain Res. 546, 3339.
  • Walsh S. L. and Wagner G. C. (1992) Motor impairments after methamphetamine-induced neurotoxicity in the rat. J. Pharmacol. Exp. Ther. 263, 617626.
  • Wong-Riley M. T. (1979) Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171, 1128.